Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Docetaxel-PM and Oxaliplatin in Esophageal Squamous Cell Carcinoma
NCT03585673Phase 2Unknown
- Start
- Jun 2018
- Primary completion
- Mar 2020
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Nanoxel M in Esophageal Squamous Cell Carcinoma (ESCC). Status: unknown.
02
Drugs
Nanoxel M
03
Conditions
Esophageal Squamous Cell Carcinoma (ESCC)
Beyond the preview
Go deeper on NCT03585673.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03585673.